European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES

Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses

by Marie Weil
April 22, 2022
A A
Share on LinkedinShare on Twitter
  • A single dose improves fibre alignment and decreases scar tissue formation
  • Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses

It takes years of diligent training as well as a trusting relationship between horse and rider to reach their full potential as a team. That’s why a tendon or ligament injury can be devastating for horse owners, riders and trainers. For equine athletes, the diagnosis may mean many months of treatment and rehabilitation with an unknown outcome, and potential for long term impact on their ability to perform. 

Boehringer Ingelheim has now received approval in Europe for RenuTend™, the first product licensed to improve healing of tendon and suspensory ligament injuries in horses. RenuTend™ is administered by intralesional injection and complements Boehringer Ingelheim’s other equine stem cell product Arti-Cell® FORTE, which is authorised to treat mild to moderate recurrent lameness associated with non-septic joint inflammation in horses. 

“We are delighted to add RenuTend™ to our portfolio of stem cell products for horses, offering veterinarians a new therapeutic option for treating tendon and suspensory ligament injuries. This product demonstrates the company’s commitment to bringing innovation to improve the lives of horses and the people who love them,” comments Liz Barrett, Head of Global Strategic Marketing, Equine at Boehringer Ingelheim. “RenuTend™ will allow more riders, owners and trainers to reimagine the dreams a tendon injury jeopardizes, by optimizing the possibilities for their horse to return to work with reduced potential for reinjury.1”

Tendon and ligament lesions don’t always heal properly, as scar tissue can be less elastic than healthy tissue, and reinjury rates can be up to 80 percent.2 This can mean the end of a career for many horses. RenuTend™ is a targeted stem cell treatment with proven efficacy and repeatable results. It improves the quality of tendon healing by promoting parallel alignment of the right type of fibres and decreases the amount of scar tissue formed. 

RenuTend™ will be available across the European Union. The approval for Great Britain is still pending. 

Tags: < New Launches

Related Industries

Health

Siemens Healthineers presents mammography system with groundbreaking new imaging technology

September 28, 2023
Chemical

New Beiersdorf plant in Leipzig officially opened

September 23, 2023
Industrial

Bosch and Karlsruhe-based measuring technology specialist Palas team up for better air quality

September 22, 2023
< INDUSTRIES

ABN AMRO intends to appoint Ton van Nimwegen as COO and member of the Executive Board

September 22, 2023
Automotive

BYD Brings eTruck Innovation to The Netherlands

September 21, 2023
Hospitality

Hilton Expands Rotterdam Portfolio with Two New Hotels

September 21, 2023

New Beiersdorf plant in Leipzig officially opened

September 23, 2023

...

Ericsson and M1 partner to deploy the new generation of 5G routers to enable a future- ready mobile transport network

September 1, 2023

...

Talking not Typing: Continental and Google Cloud Equip Cars with Generative Artificial Intelligence IAA MOBILITY 2023

September 5, 2023

...

SKF appoints Sophie Arnius as Head of Investor Relations

September 1, 2023

...

BT and Johnson Controls collaborate to help businesses reach Net Zero faster

September 14, 2023

...

Menzies Aviation renews Jazeera Airways contract in Kuwait and wins new business in Europe and Pakistan

September 6, 2023

...

ABB invests in strategic partnership with clean energy start-up to offer end-to-end wind energy portfolio

September 7, 2023

...

Air Liquide takes a further step in developing the hydrogen sector in France

September 15, 2023

...

A new Internet Levy threatens Europe’s Creative Industries and Digital Decade targets

September 16, 2023

...

Schneider Electric appoints Gwenaelle Avice-Huet as Executive Vice-President Europe Operations

September 8, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist